Review of Early Immune Response to SARS-CoV-2 Vaccination Among Patients With CKD
Edward J Carr, Andreas Kronbichler, Matthew Graham‐Brown, Graham E. Abra, Christos Argyropoulos, Lorraine Harper, Edgar V. Lerma, Rita S. Suri, Joel Michels Topf, Michelle Willicombe, Swapnil Hiremath
Abstract
glomerulonephritis, and acute transplant rejection, suggesting a need for ongoing surveillance. Studies are needed to better evaluate the effectiveness of SARS-CoV-2 vaccination in these populations. Rigorous surveillance is necessary for detection of long-term adverse effects in patients with autoimmune disease and transplant recipients. For transplant recipients and those with suboptimal immune responses, alternate vaccination platforms and strategies should be considered. As additional data arise, the NephJC COVID-19 page will continue to be updated (http://www.nephjc.com/news/covid-vaccine).